Nihon Kohden Corporation (NHNKY)
USD 14.63
(0.0%)
USD 14.63
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 221.98 Billion JPY | 7.45% |
| 2023 | 206.6 Billion JPY | 0.72% |
| 2022 | 205.12 Billion JPY | 2.7% |
| 2021 | 199.72 Billion JPY | 7.96% |
| 2020 | 185 Billion JPY | 3.47% |
| 2019 | 178.79 Billion JPY | 2.61% |
| 2018 | 174.24 Billion JPY | 4.79% |
| 2017 | 166.28 Billion JPY | 0.46% |
| 2016 | 165.52 Billion JPY | 2.93% |
| 2015 | 160.8 Billion JPY | 4.97% |
| 2014 | 153.19 Billion JPY | 15.58% |
| 2013 | 132.53 Billion JPY | 9.79% |
| 2012 | 120.71 Billion JPY | 6.47% |
| 2011 | 113.38 Billion JPY | 5.95% |
| 2010 | 107.01 Billion JPY | -1.93% |
| 2009 | 109.12 Billion JPY | 4.1% |
| 2008 | 104.82 Billion JPY | 8.43% |
| 2007 | 96.67 Billion JPY | 6.98% |
| 2006 | 90.36 Billion JPY | 7.83% |
| 2005 | 83.8 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 54.8 Billion JPY | 12.48% |
| 2024 Q3 | 52.63 Billion JPY | -3.97% |
| 2024 Q4 | 65.81 Billion JPY | 25.05% |
| 2024 FY | 221.98 Billion JPY | 7.45% |
| 2024 Q1 | 48.72 Billion JPY | -21.46% |
| 2023 Q4 | 62.04 Billion JPY | 23.58% |
| 2023 Q3 | 50.2 Billion JPY | 0.44% |
| 2023 Q1 | 44.36 Billion JPY | -22.24% |
| 2023 Q2 | 49.98 Billion JPY | 12.67% |
| 2023 FY | 206.6 Billion JPY | 0.72% |
| 2022 FY | 205.12 Billion JPY | 2.7% |
| 2022 Q1 | 47.18 Billion JPY | -24.73% |
| 2022 Q2 | 55.16 Billion JPY | 16.91% |
| 2022 Q3 | 45.73 Billion JPY | -17.09% |
| 2022 Q4 | 57.05 Billion JPY | 24.74% |
| 2021 FY | 199.72 Billion JPY | 7.96% |
| 2021 Q1 | 38.46 Billion JPY | -30.68% |
| 2021 Q2 | 48.77 Billion JPY | 26.83% |
| 2021 Q4 | 62.68 Billion JPY | 25.85% |
| 2021 Q3 | 49.8 Billion JPY | 2.11% |
| 2020 Q4 | 55.48 Billion JPY | 39.44% |
| 2020 Q1 | 38.55 Billion JPY | -34.18% |
| 2020 Q2 | 51.18 Billion JPY | 32.77% |
| 2020 Q3 | 39.79 Billion JPY | -22.26% |
| 2020 FY | 185 Billion JPY | 3.47% |
| 2019 Q3 | 41.17 Billion JPY | -7.4% |
| 2019 FY | 178.79 Billion JPY | 2.61% |
| 2019 Q1 | 34.58 Billion JPY | -39.11% |
| 2019 Q2 | 44.46 Billion JPY | 28.58% |
| 2019 Q4 | 58.57 Billion JPY | 42.24% |
| 2018 Q1 | 33.35 Billion JPY | -40.08% |
| 2018 Q4 | 56.79 Billion JPY | 39.17% |
| 2018 FY | 174.24 Billion JPY | 4.79% |
| 2018 Q3 | 40.8 Billion JPY | -5.74% |
| 2018 Q2 | 43.29 Billion JPY | 29.81% |
| 2017 Q3 | 36.15 Billion JPY | -16.04% |
| 2017 Q2 | 43.06 Billion JPY | 37.13% |
| 2017 Q1 | 31.4 Billion JPY | -41.71% |
| 2017 FY | 166.28 Billion JPY | 0.46% |
| 2017 Q4 | 55.66 Billion JPY | 53.96% |
| 2016 Q1 | 32.68 Billion JPY | -37.77% |
| 2016 Q3 | 38.15 Billion JPY | -6.51% |
| 2016 Q4 | 53.86 Billion JPY | 41.18% |
| 2016 FY | 165.52 Billion JPY | 2.93% |
| 2016 Q2 | 40.81 Billion JPY | 24.85% |
| 2015 Q1 | 30.98 Billion JPY | -40.13% |
| 2015 FY | 160.8 Billion JPY | 4.97% |
| 2015 Q4 | 52.52 Billion JPY | 44.88% |
| 2015 Q3 | 36.25 Billion JPY | -11.66% |
| 2015 Q2 | 41.04 Billion JPY | 32.47% |
| 2014 Q4 | 51.75 Billion JPY | 50.89% |
| 2014 FY | 153.19 Billion JPY | 15.58% |
| 2014 Q1 | 30.41 Billion JPY | -26.95% |
| 2014 Q2 | 36.73 Billion JPY | 20.77% |
| 2014 Q3 | 34.29 Billion JPY | -6.63% |
| 2013 Q4 | 41.63 Billion JPY | 37.32% |
| 2013 FY | 132.53 Billion JPY | 9.79% |
| 2013 Q1 | 27.77 Billion JPY | -26.66% |
| 2013 Q2 | 32.8 Billion JPY | 18.11% |
| 2013 Q3 | 30.32 Billion JPY | -7.57% |
| 2012 Q3 | 27.54 Billion JPY | -9.21% |
| 2012 Q4 | 37.87 Billion JPY | 37.47% |
| 2012 Q2 | 30.34 Billion JPY | 21.61% |
| 2012 Q1 | 24.95 Billion JPY | -26.84% |
| 2012 FY | 120.71 Billion JPY | 6.47% |
| 2011 FY | 113.38 Billion JPY | 5.95% |
| 2011 Q1 | 23.55 Billion JPY | -26.51% |
| 2011 Q2 | 28.97 Billion JPY | 23.0% |
| 2011 Q3 | 26.74 Billion JPY | -7.67% |
| 2011 Q4 | 34.1 Billion JPY | 27.5% |
| 2010 Q2 | 27.69 Billion JPY | 24.97% |
| 2010 Q1 | 22.15 Billion JPY | -28.1% |
| 2010 FY | 107.01 Billion JPY | -1.93% |
| 2010 Q4 | 32.05 Billion JPY | 27.63% |
| 2010 Q3 | 25.11 Billion JPY | -9.31% |
| 2009 FY | 109.12 Billion JPY | 4.1% |
| 2009 Q3 | 24.45 Billion JPY | -9.85% |
| 2009 Q4 | 30.81 Billion JPY | 26.02% |
| 2009 Q2 | 27.12 Billion JPY | 0.0% |
| 2008 FY | 104.82 Billion JPY | 8.43% |
| 2007 FY | 96.67 Billion JPY | 6.98% |
| 2006 FY | 90.36 Billion JPY | 7.83% |
| 2005 FY | 83.8 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AVITA Medical, Inc. | 50.56 Million USD | -438945.853% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | -28153.889% |
| QHSLab, Inc. | 1.4 Million USD | -15754817.512% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | -28153.889% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 11.98 Million USD | -1852638.249% |
| Aurora Spine Corporation | 14.52 Million USD | -1528683.295% |
| BrainsWay Ltd. | 31.78 Million USD | -698298.616% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 714.7 Thousand USD | -31059577.519% |
| Hamilton Thorne Ltd. | 68.45 Million USD | -324164.5% |
| Vivos Inc. | 19.5 Thousand USD | -1138389643.59% |
| Kelyniam Global, Inc. | 2.67 Million USD | -8306649.435% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | -108967197.931% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | -256305176.527% |
| Avitar, Inc. | 3.1 Million USD | -7146371.996% |
| Nanomix Corporation | 15.45 Thousand USD | -1436802488.997% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | -421838.378% |
| Theraclion SA | 1.82 Million USD | -12182066.708% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 734.66 Thousand USD | -30215807.637% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | -16457839.158% |
| Lombard Medical, Inc. | 12.16 Million USD | -1824092.621% |
| ALR Technologies Inc. | 7468.00 USD | -2972495882.86% |
| Stratec SE | 289.14 Million USD | -76672.232% |
| Vycor Medical, Inc. | 1.46 Million USD | -15198133.06% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 950.72 Million USD | -23249.128% |
| VMS Rehab Systems, Inc. | 71.70 USD | -309603905060.391% |
| NewCardio, Inc. | 257.39 Thousand USD | -86241882.292% |
| Guided Therapeutics, Inc. | 98 Thousand USD | -226516226.531% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | -30802283.311% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | -262754977.885% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | -33555337.987% |
| SANUWAVE Health, Inc. | 20.39 Million USD | -1088173.36% |
| IR-Med Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | -55010518.71% |
| Polarean Imaging plc | 890.93 Thousand USD | -24916027.251% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | -7801847.376% |
| Medical Supply International USA, Inc. | 2.81 Million USD | -7879047.55% |
| Urologix, Inc. | 14.23 Million USD | -1559338.005% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | -6721096.57% |
| SS Innovations International, Inc. | 5.87 Million USD | -3775358.313% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | -552547504.231% |
| Smith & Nephew plc | 5.68 Billion USD | -3806.355% |
| NIOX Group Plc | 46.84 Million USD | -473759.251% |
| Fuse Medical, Inc. | 16.11 Million USD | -1377370.349% |
| Broncus Holding Corporation | 10.25 Million USD | -2164561.141% |
| Brain Scientific Inc. | 214.56 Thousand USD | -103459007.772% |
| Pressure BioSciences, Inc. | 1.97 Million USD | -11223995.101% |
| Health Logic Interactive Inc. | - USD | -Infinity% |